• AAPL 169.02
  • TSLA 162.13
  • AMZN 176.59
  • MSFT 409.06
  • INTC 34.5
  • EURUSD 1.0702
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. ARGX.NASDAQ

argenx NV ADR (ARGX NASDAQ) stock market data APIs

$380.85 5.85(1.6%) as of April 24, 2024

argenx NV ADR Financial Data Overview

375
380.85
-
380.85
372.68
327.725-550.76
22 203 M
59 431 K
1 269 M
-1.68
0.355
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ARGX',
Type: 'Common Stock',
Name: 'argenx NV ADR',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '2017-05-18',
InternationalDomestic: 'International/Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'ADR',
IsDelisted: false,
}

argenx NV ADR Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 269 M
  • EBITDA -316 815 008
  • Earnings Per Share -5.17
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get argenx NV ADR Earnings via APIs

  • Latest Release 2024-02-29
  • EPS/Forecast -1.7

Get argenx NV ADR End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get argenx NV ADR latest news via APIs

argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease

argenx SE ADHERE data show VYVGART®Hytrulo has potential to be first advancement for CIDP patients in 30 years Real-world data demonstrate gMG patients able to significantly reduce steroid use over...

Harbor Capital Appreciation Fund Adjusts Portfolio, NVIDIA Corp Sees a 2.1% Impact

Insights from the Latest N-PORT Filing Reveal Strategic Investment Changes Harbor Capital Appreciation Fund (Trades, Portfolio), a prominent investment vehicle under the stewardship of Jennison Assoc...
Do you have any questions?
support@eodhistoricaldata.com